Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
Instituto de Salud Carlos III · Hospital Universitario de La Princesa · +2 more institutions
Abstract
To review the frequency with which infliximabloses its effect and dose "intensification" is required for Crohn's disease treatment.
Bibliographical searches were performed in MEDLINE, and European (ECCO) and American (DDW) Congresses. Studies evaluating loss of efficacy and requirement of infliximab dose intensification-defined either as an increase of the infliximab dose (generally from 5 mg/kg to 10 mg/kg) or as a decrease in the frequency of infusion (to as often as every 4 weeks)-in Crohn's disease patients were included.
Citation impact
- FWCI
- 14.84
- Percentile
- 100%
- References
- 53
Authors
2- JPJavier P. GisbertCorresponding
Instituto de Salud Carlos III, Hospital Universitario de La Princesa, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- JPJulián Panés
Instituto de Salud Carlos III, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
Topics & keywords
- Infliximab
- Medicine
- Crohn's disease
- Regimen
- Incidence (geometry)
- Internal medicine
- Disease
- Surgery
- Good health and well-being